Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Copenhagen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Novo Nordisk A/S

+ Add to Watchlist

NOVOB:DC

377.000 DKK 5.000 1.34%

As of 11:05:22 ET on 04/01/2015.

Company Profile for Novo Nordisk A/S (NOVOB)

Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.

Contact Information

Novo Nordisk A/S

Novo Alle
Bagsvaerd, 2880
Denmark
Phone: 45-44-44-88-88
Fax: 45-44-49-05-55

Key Executives for Novo Nordisk A/S (NOVOB)

Lars Rebien SorensenChief Executive OfficerKaare SchultzPresident/COO
Jesper BrandgaardExec VP/CFOLars Fruergaard JorgensenExec VP/CIO
Mads Krogsgaard ThomsenExec VP/Chief Science OfficerJakob RiisExec VP: Marketing,Medic Affers&Stakehold ENG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil